Difference between revisions of "Part:BBa K4165017"
Line 5: | Line 5: | ||
A flexible 6 aa Glycine-Serine linker | A flexible 6 aa Glycine-Serine linker | ||
− | + | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | A flexible linker with G and S aa residues with variable lengths. According to our project, 3 flexible linker required one for our clamps for binding of Tau or amyloid beta with our binding peptides. Second one for flexible linking between clamps and HTRA1 binding peptide. last one for binding our HTRA1 binding peptide with PDZ domain of our protease HTRA1. our linker with length [6 aa GGGGSG ] was calculated by our team for testing how it would affect interaction of our mentioned parts with each other using Pymol Software. | ||
<!-- --> | <!-- --> | ||
Line 12: | Line 13: | ||
<partinfo>BBa_K4165017 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165017 SequenceAndFeatures</partinfo> | ||
+ | ===References=== | ||
+ | 1- Yuan, S., Chan, H. S., & Hu, Z. (2017). Using pymol as a platform for computational drug design. WIREs Computational Molecular Science, 7(2). doi:10.1002/wcms.1298 | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Revision as of 10:07, 8 October 2022
GGGGSG Linker
A flexible 6 aa Glycine-Serine linker
Usage and Biology
A flexible linker with G and S aa residues with variable lengths. According to our project, 3 flexible linker required one for our clamps for binding of Tau or amyloid beta with our binding peptides. Second one for flexible linking between clamps and HTRA1 binding peptide. last one for binding our HTRA1 binding peptide with PDZ domain of our protease HTRA1. our linker with length [6 aa GGGGSG ] was calculated by our team for testing how it would affect interaction of our mentioned parts with each other using Pymol Software.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
1- Yuan, S., Chan, H. S., & Hu, Z. (2017). Using pymol as a platform for computational drug design. WIREs Computational Molecular Science, 7(2). doi:10.1002/wcms.1298